-
A11224
Linagliptin (BI-1356)
Linagliptin is a DPP-4 inhibitor, an enzyme that degrades the incretin hormones ...Starting at: $150.00
-
A11560
SYN-115
SYN115 is an orally administered, potent and selective inhibitor of the adenosin ...Starting at: $150.00
-
A11785
LX 1606
LX 1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) ...Starting at: $150.00
-
A11786
CPI-613
CPI-613 is a racemic mixture of the enantiomers of a synthetic alpha-lipoic lip ...Starting at: $90.00
-
A11784
GSK2636771
GSK2636771 is a potent, orally bioavailable, PI3K beta-selective inhibitor. ...Starting at: $150.00
-
A11328
BYL719
BLY719 is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor ...Starting at: $280.00
-
A11293
AR-C155858
AR-C155858 is a potent inhibitor of monocarboxylat ...Starting at: $350.00
-
A11773
ASP3026
ASP3026 is a novel and selective inhibitor for the ALK kinase. ASP3026 potently ...Starting at: $280.00
-
A10374Everolimus (RAD001)
Everolimus (RAD-001) is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an mTOR inhibitor. -
A11260MLN4924
NAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival. -
A10988WP1130
WP1130 is a novel selective small molecular deubiquitinase inhibitor and a Bcr/Abl destruction pathway activator that specifically and rapidly down-regulates both wild-type and mutant Bcr/Abl protein without affecting bcr/abl gene expression in chronic myelogenous leukemia (CML) cells. -
A10289Daptomycin
Daptomycin is a lipopeptide antibiotic used in the treatment of certain infections caused by Gram-positive organisms.
-
A10199CHIR-99021
CHIR99021 is an aminopyrimidine derivative that inhibits GSK3α and GSK3β with IC50 values of 10 and 6.7 nM, respectively. -
A12025Caftaric acid
Caftaric acid is a non-flavanoid that impacts the color of white wine. -
A10657Nutlin-3
MDM2 antagonist nutlin-3 is a potent inducer of apoptosis. -
A11289Apremilast (CC 10004)
Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis.
-
A11130PU-H71
PU-H71 is a potent Hsp90 inhibitor (IC50 = 50 nM). -
A11131MPC-3100
MPC-3100 is an orally bioavailable, synthetic, second-generation small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity. -
A11192PF-562271
PF-562271 is an orally bioavailable small molecule and ATP-competitive focal adhesion kinase (FAK) inhibitor with potential antineoplastic and antiangiogenic activities. -
A10701PD 0332991 HCl
PD 0332991 HCl is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity.
-
A11160SL 0101-1
SL 0101-1 is a selective inhibitor of p90 ribosomal S6 kinase (RSK) (IC50 = 89 nM for RSK2). It also inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line.
-
A10377EX 527
EX 527 is a potent and selective SIRT1 class III histone deacetylase enzyme inhibitor. -
A11269IPI-504 (Retaspimycin hydrochloride)
IPI-504 is a novel, water-soluble, potent inhibitor of heat-shock protein 90 (Hsp90). -
A10602MLN9708
MLN9708 is a proteasome inhibitor, which inhibits the activity of the proteasome, blocking the targeted proteolysis normally performed by the proteasome.
-
A11206CK-1827452 (Omecamtiv mecarbil)
CK-1827452 is a selective cardiac specific myosin activator.









